Drugs / donor-derived NK cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03366064 | Nov 2017 → Sep 2018 | non-small cell lung carcinoma | Asan Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | donor-derived NK cells | “donor-derived NK cells via a central venous catheter” NCT03366064 ↗ |
| Modality | Cell therapy | “natural killer (NK) cells derived from haploidentical family donors” NCT03366064 ↗ |
| Route | Intravenous | “donor-derived NK cells via a central venous catheter” NCT03366064 ↗ |